ERGO Share PerformanceMore
|52 week high||225.00 23/10/17|
|52 week low||163.10 18/09/17|
|52 week change||11.00 (6.38%)|
|4 week volume||132,500 25/12/17|
Latest News« previous» nextMore
10/01/2018 - 13:00 RNS
Notification of major interests in shares
15/12/2017 - 09:19 StockMarketWire
Ergomed has announced changes to its board and management team with the appointment of Stephen Stamp as chief exe...
15/12/2017 - 07:00 RNS
Notification of any change to a companys board e.g. appointments/resignations/changes to important functions or executive responsibilities of a director
12/12/2017 - 08:55 StockMarketWire
Ergomed has announced a multi-product, multi-study co-development partnership with Allergy Therapeutics to support th...
12/12/2017 - 07:00 RNS
Statement regarding an alliance between entities
04/12/2017 - 09:33 StockMarketWire
Ergomed's pharmacovigilance subsidiary PrimeVigilance will be organising and presenting at the International Society of ...
04/12/2017 - 07:00 RNS
27/11/2017 - 08:55 StockMarketWire
Ergomed executive vice-chairman Dr. Miroslav Reljanovic will be presenting at the German Equity Forum 2017 at The Sh...
|Dividend yield||0 %|
Latest discussion posts More
“If you would like to hear management present the preliminary results for the year ended 31 December 2016 for Ergomed we will be hosting a webinar on Wednesday 29th March at ...”▼
“If you would like to hear Stephen Stamp, Chief Finance Officer, present on behalf of Ergomed he will be appearing at our next investor forum on the evening of Wednesday 25th of ...”▼
Codes & Symbols
|Symbols||ERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO|
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment